Studies on the Enantiomers of RC-33 as Neuroprotective Agents: Isolation, Configurational Assignment, and Preliminary Biological Profile. Issue 11 (7th September 2013)
- Record Type:
- Journal Article
- Title:
- Studies on the Enantiomers of RC-33 as Neuroprotective Agents: Isolation, Configurational Assignment, and Preliminary Biological Profile. Issue 11 (7th September 2013)
- Main Title:
- Studies on the Enantiomers of RC-33 as Neuroprotective Agents: Isolation, Configurational Assignment, and Preliminary Biological Profile
- Authors:
- Rossi, Daniela
Pedrali, Alice
Marra, Annamaria
Pignataro, Luca
Schepmann, Dirk
Wünsch, Bernhard
Ye, Lian
Leuner, Kristina
Peviani, Marco
Curti, Daniela
Azzolina, Ornella
Collina, Simona - Abstract:
- <abstract abstract-type="main"> <title>ABSTRACT</title> <p>In this study we addressed the role of chirality in the <named-content id="d469e789" content-type="chemicalTechnology" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink">biological activity</named-content> of <bold>RC-33</bold>, recently studied by us in its racemic form. An <named-content id="d469e794" content-type="reactionType chemicalTechnology" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink">asymmetric synthesis</named-content> procedure was the first experiment, leading to the desired enantioenriched <bold>RC-33</bold> but with an enantiomeric excess (<italic>ee</italic>) not good enough for supporting the in vitro investigation. An <named-content id="d469e803" content-type="reactionType" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink">enantioselective</named-content> high‐performance <named-content id="d469e806" content-type="chemicalTechnology" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink">liquid chromatography</named-content> (HPLC) procedure was then successfully carried out, yielding both <bold>RC-33</bold> enantiomers in amounts and optical purity suitable for the pharmacological study. The absolute configuration of pure enantiomers was easily assigned exploiting the <named-content id="d469e811" content-type="reactionType chemicalTechnology" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink">asymmetric synthesis</named-content><abstract abstract-type="main"> <title>ABSTRACT</title> <p>In this study we addressed the role of chirality in the <named-content id="d469e789" content-type="chemicalTechnology" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink">biological activity</named-content> of <bold>RC-33</bold>, recently studied by us in its racemic form. An <named-content id="d469e794" content-type="reactionType chemicalTechnology" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink">asymmetric synthesis</named-content> procedure was the first experiment, leading to the desired enantioenriched <bold>RC-33</bold> but with an enantiomeric excess (<italic>ee</italic>) not good enough for supporting the in vitro investigation. An <named-content id="d469e803" content-type="reactionType" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink">enantioselective</named-content> high‐performance <named-content id="d469e806" content-type="chemicalTechnology" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink">liquid chromatography</named-content> (HPLC) procedure was then successfully carried out, yielding both <bold>RC-33</bold> enantiomers in amounts and optical purity suitable for the pharmacological study. The absolute configuration of pure enantiomers was easily assigned exploiting the <named-content id="d469e811" content-type="reactionType chemicalTechnology" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink">asymmetric synthesis</named-content> previously devised. As emerged in the preliminary in vitro biological investigation, (<italic>S</italic>)‐ and <bold>(R)-RC-33</bold> possess a comparable affinity towards the σ<sub>1</sub> receptor and a very a similar behavior in the calcium influx assay, resulting in an equally effective σ<sub>1</sub> receptor agonist. Overall, the results obtained so far suggest that the interaction with the biological target is nonstereoselective and leads us to hypothesize that there is a lack of stereoselectivity in the <named-content id="d469e826" content-type="chemicalTechnology" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink">biological activity</named-content> of <bold>RC-33</bold>. <italic>Chirality 25:814–822, 2013</italic>. © 2013 Wiley Periodicals, Inc.</p> </abstract> … (more)
- Is Part Of:
- Chirality. Volume 25:Issue 11(2013:Nov.)
- Journal:
- Chirality
- Issue:
- Volume 25:Issue 11(2013:Nov.)
- Issue Display:
- Volume 25, Issue 11 (2013)
- Year:
- 2013
- Volume:
- 25
- Issue:
- 11
- Issue Sort Value:
- 2013-0025-0011-0000
- Page Start:
- 814
- Page End:
- 822
- Publication Date:
- 2013-09-07
- Subjects:
- Chirality -- Periodicals
Pharmaceutical chemistry -- Periodicals
541.22 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1520-636X ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/chir.22223 ↗
- Languages:
- English
- ISSNs:
- 0899-0042
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3181.124450
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3498.xml